Imaging Genetics in Neurodegenerative Diseases

Imaging genetics integrates neuroimaging and genomic data to elucidate the biological mechanisms underpinning neurodegenerative disorders. By linking structural and functional markers from modalities such as magnetic resonance imaging (MRI) and positron emission tomography (PET) with genetic variants, researchers seek to identify endophenotypes that predict disease onset, progression and treatment response. High-throughput genotyping platforms enable genome-wide association studies (GWAS) that uncover single nucleotide polymorphisms (SNPs) associated with quantitative imaging traits. Multivariate methods, including sparse canonical correlation analysis (SCCA) and machine-learning algorithms, facilitate the discovery of complex gene–brain associations that may elude traditional univariate approaches. Longitudinal imaging–genetics studies capture temporal dynamics of neurodegeneration, while polygenic risk scores (PRS) integrate multiple genetic effects to improve individual-level prediction. International consortia have pooled data from tens of thousands of participants to enhance statistical power and reproducibility, revealing novel susceptibility loci and mechanistic pathways across Alzheimer’s, Parkinson’s and other neurodegenerative diseases. These insights hold promise for stratified medicine, informing early diagnosis, monitoring of therapeutic effects and the development of targeted interventions.

Research from Nature Portfolio

Researchers have developed a three-way sparse canonical correlation framework that simultaneously relates genetic markers, imaging phenotypes and clinical outcomes in Alzheimer’s disease. This approach extends traditional bivariate models by introducing outcome-relevant constraints that enhance disease specificity. Applied to a large cohort, it identified robust associations among APOE variants, regional brain volumes and cognitive scores, outperforming classical SCCA in detecting mechanistic patterns. The method offers a powerful tool for dissecting the triangular relationship between genotype, brain structure and clinical progression, paving the way for mechanistic understanding and biomarker development in neurodegenerative conditions.

Imaging Genetics in Neurodegenerative Diseases publication trend

The graph below shows the total number of articles in imaging genetics in neurodegenerative diseases across all publications each year (not limited to Nature Index journals).

Technical terms

Single nucleotide polymorphism (SNP): A variation at a single DNA base position among individuals, often used as a genetic marker in association studies.

Neuroimaging quantitative trait (QT): A measurable neuroimaging feature, such as cortical thickness or regional brain volume, used as a phenotypic marker.

Sparse canonical correlation analysis (SCCA): A multivariate statistical method that identifies maximal correlations between two data sets while enforcing sparsity to select key features.

Polygenic risk score (PRS): A composite metric that aggregates the effects of multiple genetic variants to estimate an individual’s genetic predisposition to disease.

Endophenotype: An intermediate biological trait that links genetic variation to clinical manifestation, often used to improve mechanistic insight.

References

1. Statistical Learning Methods for Neuroimaging Data Analysis with Applications. Annual Review of Biomedical Data Science (2023).
2. A technical review of canonical correlation analysis for neuroscience applications. Human Brain Mapping (2020).
3. Mining Outcome-relevant Brain Imaging Genetic Associations via Three-way Sparse Canonical Correlation Analysis in Alzheimer’s Disease. Scientific Reports (2017).
4. An Improved Multi-Task Sparse Canonical Correlation Analysis of Imaging Genetics for Detecting Biomarkers of Alzheimer’s Disease. IEEE Access (2021).